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Objectives: The relationship between serum uric acid levels and cardiovascular risk factors is complex. We examined 
the association between hyperuricemia and metabolic syndrome amongst apparently healthy Taiwanese aged from 
forty to sixty-five years. 
Research Design And Methods: This cross-sectional survey was based on a population from 4 nationwide health 
screening centers in Taiwan in 2000. A total of 4,466 subjects, aged 40 to 65 years were included. Blood pressure, 
body mass index (BMI), waist circumference, HDL cholesterol, serum triglycerides, and uric acid levels were 
measured. Hyperuricemia was defined as a serum uric acid level > or = 7.0 mg/dl (420 μmol/L) in men and > or = 6.0 
mg/dl (360 μmol/L) in women, respectively. Metabolic syndrome was defined using the National Cholesterol 
Education Panel (NCEP) criteria or modified NCEP criteria (WC >90 cm in men and >80 cm in women).
Results: The prevalence of hyperuricemia was 42.4% in men and 28.7% in women, respectively. The crude odds ratios 
(ORs) of metabolic syndrome was 2.79 (and 2.68 using the modified NCEP criteria) in subjects with hyperuricemia
With increasing age (OR=1.01-1.10) and BMI (OR=1.39-1.47), the ORs of having metabolic syndrome increased 
significantly in each gender. After adjustment for age, gender, and BMI, the ORs of metabolic syndrome were 
significantly higher in subjects with hyperuricemia. 
Consclusions: The present study revealed that hyperuricemia was positively associated with metabolic syndrome and 
its individual factors. Therefore, serum uric acid levels may be applied as an additional evaluation for metabolic 
syndrome in a clinical setting. 
Table 1. Odds ratios (95% CI) of having MS derived from a multivariate logistic regression analysis categorized 
by gender using age, BMI, and uric acid groups as independent variables.  
Model 1  (MS defined by 
NCEP criteria) 
Model 2  (MS defined by
modified NCEP criteria)
Variables Men 
ORs (95% CI) 
Women 
Ors (95% CI) 
Men 
ORs (95% CI) 
Women 
ORs (95% CI) 
 Age  
(years) 
1.01(0.98-1.03) 1.09(1.05-1.13) 0.99(0.97-1.01) 1.10(1.06-1.13) 
 BMI  
(kg/m2)
1.47(1.40-1.53) 1.39(1.32-1.46) 1.42(1.36-1.48) 1.47(1.40-1.55) 
 UA group 1 1 1 1 
Grade 1* 
Grade 2 
Grade 3 
Grade 4 
1.50(1.16-1.95) 
1.60(1.20-2.14) 
1.67(1.14-2.42) 
2.28(1.37-3.80) 
1.48(1.00-2.20) 
2.00(1.17-3.40) 
2.48(1.12-5.49) 
6.58(2.33-18.60) 
1.45(1.15-1.83) 
1.61(1.24-2.10) 
1.65(1.16-2.35) 
2.32(1.39-3.86) 
1.22(0.84-1.77) 
1.72(1.03-2.86) 
2.35(1.10-5.03) 
4.24(1.49-12.11) 
*Grade 1 was defined by uric acid level•7 ~7.99 in men and 6~6.99 in women; 
 Grade 2 was defined by uric acid level•8 ~8.99 in men and 7~7.99 in women; 
 Grade 3 was defined by uric acid level•9~9.99 in men and 8~8.99 in women;   
 Grade 4 was defined by uric acid level••10 in men and •9 in women  
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Metabolic syndrome (MS) is described by the presence of abdominal obesity,
hyperglycemia, hypertension and dyslipidemia, associated with increased 
cardiovascular risk. In this study MS prevalence in an obese population was 
evaluated according to ATP-III-2001, ATP-III-2005 and IDF-2005. 
Patients were evaluated in their first morbid obesity appointment, regarding
anthropometric variables, blood pressure, fasting plasma levels of glucose, LDL-C, 
HDL-C and triglycerides.
262 women having 40.9 ± 11.3 years old and 45.4 ± 6.3Kg/m2 BMI were evaluated. 
MS was observed in 63.0%, 66.8% and 66.4%, according to ATP-III-2001, ATP-III-
2005 and IDF-2005, respectively. Hypertension prevalence was 83.2% (218/262 
revealed systolic blood pressure >/=130mmHg and/or diastolic blood pressure 
>/=85mmHg, or under therapeutic). 38.9% revealed triglycerides concentration 
>/=150mg/dL, or under therapeutic. Waist circumference was > 88cm in 98.5% and 
> 80cm in 99.2%. Fasting plasma glucose (FPG) was >/= 110mg/dL in 39.3% and 
48.5%  > 100mg/dL; 43.9% showed HDL-C < 50mg/dL. 
40 men having an age average of 39.6 ± 13.3 years and mean BMI of 44.7±4.9Kg/m2
was evaluated. MS condition was observed in 85% according to ATP-III-2001 
criteria and 95% to ATP-III-2005 and IDF criteria. All men had a waist 
circumference > 102cm. There was a high prevalence of hypertension (92.5%) and 
hypertriglyceridemia (42.5%). FPG was >/= 110mg/dL in 47.5% and > 100mg/dL in 
62.5%. 52.5% had HDL-C < 40mg/dL. 
This study revealed that MS prevalence in the analyzed samples was high. The 
reduction of cut-off of waist circumference did not have influence on the prevalence 
of MS in this sample. 
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Fenugreek (Trigonella foenum-graecum L. Leguminosae) is one of the oldest 
medicinal plants, much cultivated in India and Mediterranean countries.  It is 
one of the spices which are contained in curry powder. Fenugreek has various 
medical effects such as nourishing, lactation stimulant, treatment of indigestion 
and anti-inflammatory.  Recently, hypoglycemic effect of fenugreek on type1 
and type2 diabetes was reported. However, its mechanism is still uncertain. 
And it is difficult to apply fenugreek to foodstuff, because fenugreek has a 
strong bitter taste. 
  Furostanol saponins contained in fenugreek are major cause for bitterness. 
Enzymatic cleavage at the O-linked sugar chain of fenugreek saponins yielded 
fenugreek with reduced bitterness (FRB). To evaluate the effect of FRB on 
diabetes and investigate its mechanism, we examined the effects of FRB on the 
metabolism of glucose and lipid in obese diabetic KK-Ay mice. 
  Hyperglycemia accompanied with obesity was ameliorated in KK-Ay mice fed 
with FRB. Glucose tolerance was also improved in mice fed with FRB. This 
treatment increased the expression of peroxisome proliferator-activated 
receptor ?(PPAR?) and PPAR? target genes, while decreased slightly the 
expression of macrophage-specific genes in white adipose tissue. Moreover, 
hyperlipidemia and hepatosteatosis were ameliorated in mice fed with FRB. 
Interestingly, this treatment decreased the expression of sterol regulatory 
element-binding proteins1c (SREBP1c) and SREBP1c target genes in liver.  
These results indicate that FRB improves the disorder of glucose and lipid 
metabolism. Consequently, FRB may be useful for ameliorating diabetes 
accompanied with obesity. 
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Introduction: Metabolic syndrome (MS) is associated with insulin resistance 
(IR), and MS increases the risks of cardiovascular morbidity and mortality. 
Ferritin was found to be associated with IR in some studies. 
Aim: To investigate the relationship between ferritin and MS. 
Material and methods: Tao-Yuan General Hospital conducted the annual 
physical examination for an electronic factory in 2002. The workers with 
elevated alanine transaminase were excluded because it was associated with 
ferritin level. MS was diagnosed as the criteria of ATP-III with the following 
changes: waist circumference: male > = 90 cm or female > = 80 cm and fasting 
sugar > = 100 mg/dl. 
Results: 3380 workers recruited in our analyses with male to female ratio as 
65:35. The mean age was 34.1 ± 8.2 years old and the BMI was 23.3 ± 3.5. 
Fatty liver was found in 28.3%. MS was found in 12.9% of workers. Using 
logistic regression analyses, we found that fatty liver, more age, BMI, IR and 
ferritin were associated with MS. If we regarded ferritin as linear data, the odds 
ratio (OR) to have MS was 1.002 in each unit increase (ng/ml). Using ferritin < 
100 as reference, the OR of ferritin between 100-300 was 1.6 ( 95% C.I. 1.2-
2.0), and the OR of ferritin > 300 was 2.7 (95% C.I. 1.8-4.1).  
Conclusion: Ferritin was associated with MS significantly. Physicians should 
take care of the older, obese workers with high ferritin level and fatty liver 
because they carry higher risk to have MS. 
